Subjects to be considered in partial replicate BE study [RSABE / ABEL]

posted by cher0424 – China, 2015-01-08 09:51 (2567 d 15:10 ago) – Posting: # 14249
Views: 27,085

Dear Detlew

Sorry to ask again, but I can't see any contradiction between point 1 and 3.
And to point 1 and 2, subjects who complete at least two periods with at least one test and one reference treatment of the study will be included in the pharmacokinetic and statistical analysis,so then can be considered for Bioequivalence.

Is it causal relationship between 1 and 2??
And do you know any literature about statistical analysis of partial replicate BE study?

Complete thread:

 Admin contact
21,831 posts in 4,567 threads, 1,553 registered users;
online 2 (0 registered, 2 guests [including 2 identified bots]).
Forum time: Wednesday 01:01 CET (Europe/Vienna)

Research under a paradigm must be a particularly effective way
of inducing paradigm change.    Thomas S. Kuhn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz